149 related articles for article (PubMed ID: 17390261)
21. Tardive dyskinesia: prevalence, incidence, and risk factors.
Kane JM; Woerner M; Lieberman J
J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):52S-56S. PubMed ID: 3065365
[TBL] [Abstract][Full Text] [Related]
22. Clinical and familial correlates of tardive dyskinesia in India and Israel.
Bhatia T; Sabeeha MR; Shriharsh V; Garg K; Segman RH; Uriel HL; Strous R; Nimgaonkar VL; Bernard L; Deshpande SN
J Postgrad Med; 2004; 50(3):167-72; discussion 172. PubMed ID: 15377799
[TBL] [Abstract][Full Text] [Related]
23. Tardive dyskinesia in the course of antidepressant therapy: a prevalence study and review of the literature.
Yassa R; Camille Y; Belzile L
J Clin Psychopharmacol; 1987 Aug; 7(4):243-6. PubMed ID: 3624506
[TBL] [Abstract][Full Text] [Related]
24. The prevalence of tardive dyskinesia in fluphenazine-treated patients.
Yassa R; Iskandar H; Ally J
J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):17S-20S. PubMed ID: 3220966
[TBL] [Abstract][Full Text] [Related]
25. Tardive dyskinesia and essential fatty acids.
Vaddadi K; Hakansson K; Clifford J; Waddington J
Int Rev Psychiatry; 2006 Apr; 18(2):133-43. PubMed ID: 16777667
[TBL] [Abstract][Full Text] [Related]
26. [Neuroleptic-induced tardive dyskinesias in France].
Bourgeois M
Encephale; 1988 Sep; 14 Spec No():195-201. PubMed ID: 2905646
[TBL] [Abstract][Full Text] [Related]
27. Systematic review of cholinergic drugs for neuroleptic-induced tardive dyskinesia: a meta-analysis of randomized controlled trials.
Tammenmaa IA; Sailas E; McGrath JJ; Soares-Weiser K; Wahlbeck K
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1099-107. PubMed ID: 15610922
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics?
Tarsy D; Baldessarini RJ
Mov Disord; 2006 May; 21(5):589-98. PubMed ID: 16532448
[TBL] [Abstract][Full Text] [Related]
29. [Tardive dyskinesia: etiology, clinical features and therapy].
Furer V; Lichtenberg P; Heresco-Levy U
Harefuah; 2001 Mar; 140(3):248-52. PubMed ID: 11303354
[No Abstract] [Full Text] [Related]
30. Melatonin for the treatment of tardive dyskinesia.
Nelson LA; McGuire JM; Hausafus SN
Ann Pharmacother; 2003; 37(7-8):1128-31. PubMed ID: 12841828
[TBL] [Abstract][Full Text] [Related]
31. Anticholinergic antiparkinsonian drugs in psychiatry.
Boodhoo JA; Sandler M
Br J Hosp Med; 1991 Sep; 46(3):167-9. PubMed ID: 1681972
[TBL] [Abstract][Full Text] [Related]
32. What may be gained from neuropsychological investigations of tardive dyskinesia?
Cohen H; Cohen D
Brain Cogn; 1993 Sep; 23(1):1-7. PubMed ID: 8105818
[TBL] [Abstract][Full Text] [Related]
33. A monkey model of tardive dyskinesia (TD): evidence that reversible TD may turn into irreversible TD.
Kovacic B; Domino EF
J Clin Psychopharmacol; 1982 Oct; 2(5):305-7. PubMed ID: 6890075
[TBL] [Abstract][Full Text] [Related]
34. Tardive dyskinesia rating scales.
Simpson GM; Singh H
Encephale; 1988 Sep; 14 Spec No():175-82. PubMed ID: 3063512
[TBL] [Abstract][Full Text] [Related]
35. Tardive dyskinesia.
Bsoul SA; Terezhalmy GT; Riley CK; Moore WS
Quintessence Int; 2002 Apr; 33(4):326-7. PubMed ID: 11989382
[No Abstract] [Full Text] [Related]
36. Tardive dyskinesia: pharmacology and clinical implications.
Goetz CG; Weiner WJ; Nausieda PA; Klawans HL
Clin Neuropharmacol; 1982; 5(1):3-22. PubMed ID: 7046923
[TBL] [Abstract][Full Text] [Related]
37. Clinical and neuropathological abnormalities in baboons treated with HPTP, the tetrahydropyridine analog of haloperidol.
Halliday GM; Pond SM; Cartwright H; McRitchie DA; Castagnoli N; Van der Schyf CJ
Exp Neurol; 1999 Jul; 158(1):155-63. PubMed ID: 10448427
[TBL] [Abstract][Full Text] [Related]
38. Current topics in tardive dyskinesia in Japan.
Inada T; Yagi G
Psychiatry Clin Neurosci; 1995 Dec; 49(5-6):239-44. PubMed ID: 8726107
[TBL] [Abstract][Full Text] [Related]
39. Estrogen receptor activation and tardive dyskinesia.
Turrone P; Seeman MV; Silvestri S
Can J Psychiatry; 2000 Apr; 45(3):288-90. PubMed ID: 10779888
[TBL] [Abstract][Full Text] [Related]
40. Treatment of neuroleptic-induced tardive dyskinesia with levetiracetam: a case series.
Bona JR
J Clin Psychopharmacol; 2006 Apr; 26(2):215-6. PubMed ID: 16633158
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
